1100 13th Street, NW, Suite 1000Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2020The Kiplinger Washington Editors
The drug maker offers a healthy product pipeline including cancer-fighter Keytruda to go along with its healthy yield.
The bond king’s abrupt move to Janus raises more doubts about Pimco’s portfolios
Despite an exodus of managers, this mutual fund firm is bouncing back from bad years -- and its shares look appealing.
More Investing News »